CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.45−0.05 (-3.33%)
Close on Nov 18, 2026Market cap $21.92MP/E –Yield –
CervoMed operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
CervoMed's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.98M. For fiscal 2025 it was -$23.45M. The highest annual figure on record is -$1.18M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.45M | – |
| FY2024 | Dec 31, 2024 | -$16.53M | – |
| FY2023 | Dec 31, 2023 | -$7.45M | – |
| FY2022 | Dec 31, 2022 | -$2.57M | – |
| FY2021 | Dec 31, 2021 | -$14.50M | – |
| FY2020 | Dec 31, 2020 | -$13.55M | – |
| FY2019 | Dec 31, 2019 | -$9.86M | – |
| FY2018 | Dec 31, 2018 | -$10.77M | – |
| FY2017 | Dec 31, 2017 | -$12.33M | – |
| FY2016 | Dec 31, 2016 | -$10.77M | – |
| FY2015 | Dec 31, 2015 | -$5.19M | – |
| FY2014 | Dec 31, 2014 | -$9.03M | – |
| FY2013 | Dec 31, 2013 | -$1.18M | – |
| FY2012 | Dec 31, 2012 | -$4.31M | – |
| FY2011 | Dec 31, 2011 | -$12.02M | – |
| FY2010 | Dec 31, 2010 | -$1.98M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.92M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.02M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.58M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.47M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.51M | – |
| Q1 FY2025 | Mar 31, 2025 | -$3.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$8.05M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.85M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.20M | – |
| Q1 FY2024 | Mar 31, 2024 | -$1.42M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.54M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.47M | -121.4% |
| Q2 FY2023 | Jun 30, 2023 | -$1.96M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.48M | – |
| Q4 FY2022 | Dec 31, 2022 | -$692.53K | – |
| Q3 FY2022 | Sep 30, 2022 | $6.86M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.01M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.73M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.03M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.97M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.33M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.18M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.39M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.51M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.14M | – |
| Q1 FY2020 | Mar 31, 2020 | -$3.50M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.44M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.15M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.61M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.66M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.03M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.92M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.54M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.29M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.28M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.89M | – |
| Q2 FY2017 | Jun 30, 2017 | -$2.75M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.42M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.41M | – |
| Q3 FY2016 | Sep 30, 2016 | -$1.86M | – |
See a number that looks wrong?